Funding to accelerate development of RECCE® 327 Gel (R327G) for acute treatment of burn wound infections and downstream bacterial complications…
VANCOUVER, British Columbia, July 16, 2024 (GLOBE NEWSWIRE) -- Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or…
BRIDGEWATER, N.J., July 16, 2024 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical…
DURHAM, N.C., July 16, 2024 (GLOBE NEWSWIRE) -- Humacyte, Inc. (Nasdaq: HUMA), a clinical-stage biotechnology platform company developing universally implantable,…
Central AI-Immunology™ Building Block: Evaxion’s proprietary in-house developed building block, EvaxMHC, is used across the AI-Immunology™ platform Improved Performance: Utilizing…
Late Breaking Clinical Trial Presentations to Feature Additional Results from SEQUOIA-HCM Related to Patient-Reported Health Status, Cardiac Structure and Function and…
- Results will be presented at the London International Cough Symposium on July 18, 2024 - Dose dependent cough suppression…
Composition of matter patent approval underscores the Company’s solid-form technology to maximize future value and ability to strengthen and broaden…
Henry Charlton and Claire Poulard to join the Board of Directors Funding will Accelerate US Market Entry, Enhance Digital Solutions,…
REDDING, Calif., July 15, 2024 /PRNewswire/ -- According to a new market research report titled, 'Pharmaceutical Quality Management Systems Market Size,…